Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Haatch Ventures
Haatch EIS Fund
7th Jan 2025
Blackfinch Investments (Fund)
Blackfinch Ventures EIS Portfolios
2nd Dec 2024
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
109: Where are we in the venture capital cycle? | Henry Whorwood of Beauhurst
Stay up-to-date with the latest research
Sign up to our newsletter
Latest Update
Our research can be accessed for free under MIFID.
Find out more >
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
Arix Bioscience
Life Sciences
32% IRR since inception in 2016
By
Dr Martin Hall
15 Mar 2021
Primary Health Properties
Property
Results demonstrate growth as well as security
By
Mike Foster
08 Mar 2021
Stay up-to-date with the latest research
Sign up to our newsletter
Diurnal Group Plc
Life Sciences
Attention turning to Chronocort®
By
Dr Martin Hall
25 Feb 2021
ICG Enterprise Trust
Investment Companies
ICGT’s steps to value-adding portfolio construction
By
Mark Thomas
22 Feb 2021
City of London Investment Group
Financials
Karpus benefit coming through strongly
By
Dr Brian Moretta
18 Feb 2021
City of London Investment Group
Financials
Strong markets and merger support dividend hike
By
Dr Brian Moretta
22 Jan 2021
Pantheon International Plc
Investment Companies
The real costs of public vs. PE ownership
By
Mark Thomas
14 Jan 2021
Palace Capital
Property
Interim results on track – upside clear in FY’22
By
Mike Foster
24 Nov 2020
ICG Enterprise Trust
Financials
Defensive growth: explaining downside resilience
By
Mark Thomas
08 Sep 2020
Artificial Solutions
Technology
Navigating well through the COVID-19 pandemic
By
Milan Radia
02 Sep 2020
Pantheon International Plc
Investment Companies
2020 results: positioned for sustained growth
By
Mark Thomas
14 Aug 2020
Prev
1
...
10
11
12
13
14
...
30
Next
